The 12 closest competitors and alternatives to DewCell among biotechnology companies — ranked by similarity to what DewCell actually does, not by market-cap band.
Subscribe to see DewCell’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
DewCell (Dewcell Biotherapeutics) is a South Korean biotechnology company established in October 2021 and headquartered in Seongnam, South Korea. The company focuses on cutting-edge biotherapeutic research and regenerative medicine.
DewCell is a biotechnology company headquartered in South Korea. Its most recent funding round, Series C, raised $16.9M in March 2026. Xcout tracks 4 named people at DewCell, including Lee Min-woo (CEO).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series C | $16.9M | 7 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to DewCell by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
GC Cell is a public company headquartered in Yongin-si, Gyeonggi-do, South Korea. The company is at the forefront of cell therapy innovation, with fully-integrated capabilities from research to commercialization.
Similar biotechnology company
Kang Stem Biotech Co., Ltd. is a South Korean biotechnology company located in Seoul that specializes in stem cell research and development.
Biotech
IntoCell is a South Korean biotechnology company founded in 2015 and headquartered in Daejeon, specializing in drug-conjugate and related pharmaceutical technologies.
Similar biotechnology company
IMBiologics Corp. is a biotechnology company headquartered in Suwon-si, Gyeonggi-do, South Korea. The firm focuses on drug discovery, development of biotherapeutic pipelines, and clinical trials for innovative antibody treatments.
Biotech
Medipost Co., Ltd. is a South Korean biotechnology company developing and commercializing stem-cell-based regenerative medicines, including treatments derived from human umbilical cord blood mesenchymal stem cells. It also operates a cord-blood banking business serving expectant parents and families.
Biotech
LegoChem Biosciences, Inc. (LCB) is a research-based biotechnology company headquartered in Daejeon, South Korea. The company is dedicated to the discovery, development, and commercialization of innovative biotechnological solutions.
Similar biotechnology company
Dewpoint Therapeutics is an integrated drug discovery platform company headquartered in Boston, Massachusetts. The firm leverages advanced biotechnology to translate condensate biology into novel medicines for various therapeutic areas.
Biotechnology (Cancer Immunotherapeutics)
Cellid Co., Ltd. was founded in 2006 and is headquartered in Seoul, South Korea. The company leads research in anti-cancer immunotherapies and vaccines for preventing infectious diseases, operating in the biotechnology and medical research sector.
Biotech
Pharmicell develops and provides stem cell therapeutics, cell culture media, and biomedical products, alongside chemical raw materials and advanced industrial materials such as nucleosides and medical PEGs. The company serves patients, researchers, and medical institutions by offering stem cell-based treatments, contract development and manufacturing (CDMO) services, and stem cell-derived cosmetics.
Similar biotechnology company
Y-Biologics is a South Korea-based research and development biotechnology company headquartered in Daejeon. The firm focuses on developing novel antibody-based therapeutics using its proprietary platform technologies and pipelines.
Similar biotechnology company
NCC-Bio is a South Korean biopharmaceutical company founded in 2020 and headquartered in Goyang, focused on developing targeted anti-cancer strategies and therapeutics.
Similar biotechnology company
1STBIO is a South Korea-based biotherapeutics company utilizing a proprietary AI-based drug discovery platform and genomic-based target discovery to enhance R&D efficiency. The firm is dedicated to discovering and developing novel therapeutics for areas of significant unmet medical need with a small team of 29 employees.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for DewCelland every competitor above — in one live dashboard.
Subscribe to Xcout Intel →